Sibannac, Inc. (SNNC)
OTCMKTS · Delayed Price · Currency is USD
0.00478
+0.0006 (13.81%)
Sep 4, 2026, 4:00 PM EST
Sibannac Revenue
Sibannac had revenue of $434.00 in the twelve months ending November 30, 2023, down -99.54% year-over-year. In the fiscal year ending August 31, 2023, Sibannac had annual revenue of $434.00, down -93.23%.
Revenue
434.00
Revenue Growth
-99.54%
P/S Ratio
1,491.49
Revenue / Employee
434.00
Employees
1
Market Cap
647.31K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2023 | 434.00 | -5.98K | -93.23% |
| Aug 31, 2022 | 6.42K | -150.90K | -95.92% |
| Aug 31, 2021 | 157.31K | -97.75K | -38.32% |
| Aug 31, 2020 | 255.06K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Sibannac News
- 22 days ago - Sibannac announces non-binding LOI with two strategic partners - TheFly
- 26 days ago - Sibannac, Inc. (OTCID:SNNC) Enters Into Non-Binding Letter of Intent for Strategic Collaboration and Potential Reverse Merger Focused on Advancing Patient Health Potential - Accesswire
- 3 months ago - Sibannac announces development of functional mushroom products, moringa - TheFly
- 3 months ago - Sibannac, Inc. Announces Development of Functional Mushroom Products and Moringa to Expand Wellness Portfolio - Accesswire
- 3 months ago - Sibannac announces signing of LOI to form joint venture with 1120 Management - TheFly
- 3 months ago - Sibannac, Inc. (SNNC) Announces Joint Venture With 1120 Management, LLC to Develop State-of-the-Art DEA-Compliant Psilocybin Research Facility in Phoenix, Arizona - Accesswire
- 4 months ago - Sibannac anticipates surge in psychedelic tourism following executiv order - TheFly
- 4 months ago - Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch - Accesswire